ANPEP and familial pancreatic carcinoma: Consequently, a withaferin A encapsulated-liposomal formulation of NGRKC-16 lipopeptide caused apoptosis in CD13-positive pancreatic cells and antigenic endothelial cells, which could be used in the treatment of aggressive pancreatic cancer cells [254].